• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jasper Therapeutics, Inc. - Class A Common Stock (NQ:JSPR)

0.6884 -0.0407 (-5.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 674,156
Open 0.7000
Bid (Size) 0.6900 (1,000)
Ask (Size) 0.7200 (900)
Prev. Close 0.7291
Today's Range 0.6810 - 0.7397
52wk Range 0.3151 - 3.250
Shares Outstanding 736,213
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Friday's session: top gainers and losers ↗
July 17, 2026
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
July 17, 2026
Gainers Jasper Therapeutics (NASDAQ:JSPR) stock moved upwards by 19.2% to $0.92 during Friday's regular session. The company's market cap stands at $21.6 million. Kalaris Therapeutics (NASDAQ:KLRS)... 
Via Benzinga

Performance

YTD
-62.6%
-62.6%
1 Month
+55.5%
+55.5%
3 Month
-26.0%
-26.0%
6 Month
-55.0%
-55.0%
1 Year
-78.1%
-78.1%

More News

Read More
The trading volume of these stocks is deviating from the norm in today's session. ↗
July 17, 2026
Via Chartmill
The market is filled with gapping stocks in Friday's session. ↗
July 17, 2026
Via Chartmill
News headline image
Jasper Therapeutics Announces Merger with Kira Pharmaceuticals
July 16, 2026
From Jasper Therapeutics, Inc.; Kira Pharmaceuticals
Via GlobeNewswire
Top movers analysis one hour before the close of the markets on 2026-06-26: top gainers and losers in today's session. ↗
June 26, 2026
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
May 19, 2026
Via Chartmill
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
April 02, 2026
Via Chartmill
Here are the top movers in Thursday's session. ↗
January 08, 2026
Via Chartmill
These stocks are gapping in today's session ↗
January 08, 2026
Via Chartmill
News headline image
These stocks have an unusual volume in today's session ↗
December 03, 2025
Via Chartmill
News headline image
$1 Stocks to Watch: JSPR, FTEL, BYND, TOON December 2025 More Inside
December 02, 2025
Via AB Newswire
News headline image
These stocks are moving in today's pre-market session ↗
December 02, 2025
Via Chartmill
News headline image
What's going on in today's after hours session ↗
December 01, 2025
Via Chartmill
News headline image
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Driven Brands and Jasper Therapeutics on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
November 22, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Jasper Therapeutics, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 18, 2025
Via NewMediaWire
Topics Lawsuit
News headline image
JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Jasper Therapeutics, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 18, 2025
Via TheNewswire.com
Topics Lawsuit
News headline image
JSPR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Announces that Jasper Therapeutics Investors Have Opportunity to Lead Class Action Lawsuit
November 18, 2025
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
Bragar Eagel & Squire, P.C. Reminds Stockholders of Jasper, KBR, Spirit, and Molina of the Upcoming Deadlines and Urges Investors to Contact the Firm
November 17, 2025
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Deadline Soon: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
November 17, 2025
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
November 17, 2025
From Schall Law
Via GlobeNewswire
News headline image
JSPR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action – JSPR
November 16, 2025
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Jasper Therapeutics, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 14, 2025
Via NewMediaWire
Topics Lawsuit
News headline image
JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Jasper Therapeutics, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
November 14, 2025
Via TheNewswire.com
Topics Lawsuit
News headline image
JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
November 13, 2025
From Schall Law
Via GlobeNewswire

Frequently Asked Questions

Is Jasper Therapeutics, Inc. - Class A Common Stock publicly traded?
Yes, Jasper Therapeutics, Inc. - Class A Common Stock is publicly traded.
What exchange does Jasper Therapeutics, Inc. - Class A Common Stock trade on?
Jasper Therapeutics, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Jasper Therapeutics, Inc. - Class A Common Stock?
The ticker symbol for Jasper Therapeutics, Inc. - Class A Common Stock is JSPR on the Nasdaq Stock Market
What is the current price of Jasper Therapeutics, Inc. - Class A Common Stock?
The current price of Jasper Therapeutics, Inc. - Class A Common Stock is 0.6884
When was Jasper Therapeutics, Inc. - Class A Common Stock last traded?
The last trade of Jasper Therapeutics, Inc. - Class A Common Stock was at 07/24/26 04:00 PM ET
What is the market capitalization of Jasper Therapeutics, Inc. - Class A Common Stock?
The market capitalization of Jasper Therapeutics, Inc. - Class A Common Stock is 506.81K
How many shares of Jasper Therapeutics, Inc. - Class A Common Stock are outstanding?
Jasper Therapeutics, Inc. - Class A Common Stock has 507K shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap